Has anyone talked to a doctor about the off-label use of Ocrevus, the new MS infusion drug, for CIDP? Expensive drugs are given all the time for conditions they’re not FDA approved for, and insurance usually pays. IVIG, which costs considerably more than Ocrevus, is often prescribed for off-label uses. So why not Ocrevus?
You must be logged in to reply to this topic.
© Copyright GBS|CIDP Foundation International Forums.
Use of this Web site constitutes acceptance of our Terms of Use and Privacy Policy.
GBS|CIDP Foundation International is a 501(c)3 tax-exempt organization.
Cookie | Duration | Description |
---|---|---|
CONSENT | 16 years 6 months 14 days 2 hours 6 minutes | No description |
cookielawinfo-checkbox-functional | 1 year | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-others | 1 year | No description |